This content is machine translated Hand eczema: Guideline 2023 Therapy depends on the severity The new edition of the guideline “Diagnosis, prevention and treatment of hand eczema”, which was published this year under the auspices of the German Dermatological Society, focuses in particular on…
View Post 5 min This content is machine translated Antiviral therapies against COVID-19 Current recommendation for high-risk patients! The wave of colds is already well underway. The number of coronavirus infections is rising steadily again – and with it the number of infected people from potential risk groups.…
View Post 7 min This content is machine translated Harm reduction with e-cigarettes If not stop, then at least minimize the damage Worldwide, around 30-40% of cardiovascular diseases are attributable to smoking. This figure is around 80% for cancer cases and 63% for COPD cases. Around half of healthcare costs can be…
View Post 10 min This content is machine translated GLP-1 agonists continue to gain ground Semaglutide in patients with obesity and heart failure It has long been known that the active ingredient class of glucagon-like peptide-1 agonists (GLP-1) reduces cardiovascular consequences in diabetics and leads to significant weight loss in patients with obesity.…
View Post 8 min This content is machine translated Hematology From anemia to blood cancer – the latest findings at a glance Hematology covers a broad spectrum of indications with very heterogeneous disease patterns. Accordingly, intensive research is being carried out to provide patients with effective treatment. Rarer diseases are examined just…
View Post 8 min This content is machine translated Rare skin diseases Patience and expertise are required for bullous pemphigoid Direct and indirect immunofluorescence are still the gold standard for the detection of specific antibodies and autoantibodies in bullous pemphigoid. Highly effective topical steroids or systemic corticosteroids are recommended as…
View Post 13 min This content is machine translated Gerontopsychiatry Focus on polypharmacy – challenges and solutions With age, diseases increase – and so does the likelihood of polypharmacy. However, this presents many challenges, as the heterogeneity and vulnerability of older people requires a differentiated approach. Patients… CME-Test
View Post 4 min This content is machine translated SGLT-2-i in type 2 diabetes and CVD Cardioprotective mechanisms of action of empagliflozin – what’s new? Empagliflozin is known to reduce the risk of atherosclerotic cardiovascular disease (CVD) in people with type 2 diabetes and high cardiovascular risk. The mechanisms underlying these effects are not yet…
View Post 2 min This content is machine translated Inpatient psychiatry Effective treatments and fewer measures that restrict freedom The results of the 2022 quality measures in adult and child and adolescent psychiatry have been published. They show that inpatient treatments led to a significant decrease in patients’ average…
View Post 3 min This content is machine translated IBD and exposure to altitude Don’t fly so high, sick patient Inflammatory bowel disease (IBD) can have many causes. However, the connection with exposure to altitude has not yet been investigated prospectively. Scientists from Zurich have now approached this question with…
View Post 3 min This content is machine translated Journal Club Atopic dermatitis and the skin microbiome: new study findings Exploring the links between the cutaneous microbiome and the severity of atopic dermatitis (AD) and patient-related co-factors is an important aspect in the development of new personalized AD therapies, especially…
